Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Single Arm Study of PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility Study

NCT06608459 is registered in ClinicalTrials.gov with Filament Health Corp. as lead sponsor.

NCT NCT06608459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06608459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Single Arm Study of PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility Study
Lead sponsor
Filament Health Corp.
Phase
Phase 2
Overall status
Not yet recruiting
Start date
December 31, 2024
Completion date
June 30, 2027
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder